Status:
UNKNOWN
Determining the Risk Elevation After Maternity
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
The Ottawa Hospital Academic Medical Association
Conditions:
Preeclampsia
Eligibility:
FEMALE
18+ years
Brief Summary
Evaluating the long term cardiovascular risks of those mothers who have been diagnosed with preeclampsia in pregnancy.
Detailed Description
Preeclampsia is a complication of pregnancy that happens in about 5-7% of all births. It is diagnosed when a mother has high blood pressure in pregnancy combined with protein in the urine which is sig...
Eligibility Criteria
Inclusion
- Women with a pregnancy complicated by pre-eclampsia and women who are healthy and have had a normal singleton pregnancy(controls)
Exclusion
- Women with any of the following conditions will be excluded in both the control \& preeclampsia groups:
- known kidney disease prior to pregnancy or laboratory evidence of proteinuria prior to pregnancy
- diabetes (Type I, Type II or Gestational Diabetes)
- known Cardiovascular Disease (myocardial infarction, angina, stroke, or transient ischemic attack
- multiple pregnancies (twins or more)
- who do not understand English or French will be excluded In addition to those listed above, for the control group, women must have no other major maternal pregnancy complications.
Key Trial Info
Start Date :
August 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT02305745
Start Date
August 1 2015
End Date
December 1 2019
Last Update
September 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital, General Campus
Ottawa, Ontario, Canada, K1H 8L6